Loading...
Clinical Trials: past, current and future for atypical parkinsonian syndromes
There are currently no effective, Food and Drug Administration (FDA) approved treatments for atypical parkinsonian disorders such as progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), dementia with lewy bodies (DLB) or multiple system atrophy (MSA). Previous treatment trials for...
Na minha lista:
| Udgivet i: | Semin Neurol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4920046/ https://ncbi.nlm.nih.gov/pubmed/24963682 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0034-1381739 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|